Home ›
Trademark Categories ›
Pharmaceuticals ›
2011 ›
TA ›
TABNAXA
Trademark search for:
TABNAXA
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2011-12-21 — Application filed
2011-12-24 — Application filed
2012-01-03 — Application filed
2012-03-27 — Assigned to examiner
2012-03-28 — Final disposition recorded
2012-03-28 — Final disposition recorded
2012-03-28 — Final disposition recorded
2012-07-09 — Attorney/dom.rep.revoked and/or appointed
2012-07-09 — Teas revoke/app/change addr of atty/dom rep received
2012-09-24 — Office action issued
2012-10-02 — Assigned to lie
2012-10-02 — Assigned to lie
2012-10-15 — Office action issued
2012-10-15 — Teas/email correspondence entered
2012-10-15 — Office action issued
2012-10-15 — Office action issued
2012-10-15 — Correspondence received in law office
2013-03-29 — Examiners amendment -written
2013-03-29 — Examiners amendment e-mailed
2013-03-29 — Notification of examiners amendment e-mailed
2013-03-29 — Examiner's amendment entered
2013-03-31 — Suspension letter written
2013-03-31 — Letter of suspension e-mailed
2013-03-31 — Notification of letter of suspension e-mailed
2013-10-01 — Suspension letter written
2013-10-01 — Letter of suspension e-mailed
2013-10-01 — Notification of letter of suspension e-mailed
2013-10-01 — Suspension checked - to attorney for action
2014-04-02 — Suspension letter written
2014-04-02 — Letter of suspension e-mailed
2014-04-02 — Notification of letter of suspension e-mailed
2014-10-06 — Suspension inquiry written
2014-10-06 — Inquiry to suspension e-mailed
2014-10-06 — Notification of inquiry as to suspension e-mailed
2014-10-06 — Suspension checked - to attorney for action
2015-04-01 — Teas response to suspension inquiry received
2015-04-02 — Approved for pub - principal register
2015-04-02 — Teas/email correspondence entered
2015-04-02 — Correspondence received in law office
2015-04-03 — Law office publication review completed
2015-04-22 — Notification of notice of publication e-mailed
2015-05-12 — Published for opposition
2015-05-12 — Official gazette publication confirmation e-mailed
2015-07-28 — Registered-principal register
2019-02-08 — Teas change of correspondence received
2020-07-28 — Courtesy reminder - sec. 8 (6-yr) e-mailed
2021-07-22 — Attorney/dom.rep.revoked and/or appointed
2021-07-22 — Teas change of domestic representatives address
2021-07-22 — Teas change of owner address received
2021-07-22 — Teas change of correspondence received
2021-07-22 — Applicant/correspondence changes (non-responsive) entered
2021-07-22 — Teas revoke/app/change addr of atty/dom rep received
2022-02-04 — Cancelled sec. 8 (6-yr)
2022-02-04 — Final status recorded
Owner Information
AstraZeneca AB
Södertälje SE
AstraZeneca AB
Södertälje SE-151 85 SE
AstraZeneca AB
Södertälje SE-151 85 SE
Correspondent
Cara M. Kearney AstraZeneca Pharmaceuticals LP 1800 Concord Pike, A2C Wilmington, DE 19850-5437 UNITED STATES
Filing Details
Filing Date:
2011-12-21
Status Date:
2022-02-04
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.